Corcept Therapeutics Incorporated (CORT) is a biopharmaceutical company specializing in cortisol-modulating therapies. This report evaluates its Shariah compliance across financial, business activity, ESG, and multi-perspective criteria. Overall, CORT demonstrates strong compliance, supported by inclusion in all major Shariah indices and favorable financial ratios. Minor purification is required for interest income, but no disqualifying factors are present.